Yang Zheng

5PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|Apr 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer.

Caleb Cheng, Jing Hu, Rahul Mannan

|Nov 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade.

Yi Bao, Gabriel Cruz, Yuping Zhang

|Jun 28, 2024
PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.

Jae Eun Choi, Yuanyuan Qiao, Ilona Kryczek

|Jul 17, 2023
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.

Yuanyuan Qiao, Jesse W Wotring, Yang Zheng

Pageof 1

Frequent Collaborators

5 joint publications

Yuanyuan Qiao

5 joint publications

Arul M Chinnaiyan

3 joint publications

Rui Wang

3 joint publications

Rahul Mannan